Teacher Retirement System of Texas Invests $218,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)

Teacher Retirement System of Texas purchased a new position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 49,405 shares of the company’s stock, valued at approximately $218,000.

A number of other large investors have also recently made changes to their positions in GDRX. Bank of New York Mellon Corp grew its holdings in shares of GoodRx by 10.1% during the fourth quarter. Bank of New York Mellon Corp now owns 192,612 shares of the company’s stock valued at $896,000 after buying an additional 17,633 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in GoodRx by 12.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 538,588 shares of the company’s stock valued at $2,504,000 after purchasing an additional 58,465 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in GoodRx by 1,091.7% in the fourth quarter. Victory Capital Management Inc. now owns 122,138 shares of the company’s stock valued at $568,000 after purchasing an additional 111,889 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in GoodRx in the fourth quarter valued at $2,500,000. Finally, Swiss National Bank boosted its holdings in GoodRx by 4.1% in the fourth quarter. Swiss National Bank now owns 161,400 shares of the company’s stock valued at $751,000 after purchasing an additional 6,400 shares during the last quarter. 63.77% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

GDRX has been the subject of a number of analyst reports. UBS Group decreased their price objective on shares of GoodRx from $6.00 to $5.25 and set a “neutral” rating for the company in a research report on Tuesday, May 13th. The Goldman Sachs Group reduced their price target on shares of GoodRx from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Friday, May 9th. Truist Financial reduced their price target on shares of GoodRx from $6.50 to $5.50 and set a “hold” rating for the company in a research report on Thursday, April 10th. Finally, Wells Fargo & Company reduced their price target on shares of GoodRx from $8.00 to $7.00 and set an “overweight” rating for the company in a research report on Tuesday, April 29th. Five analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $6.55.

GoodRx Price Performance

GDRX opened at $4.68 on Friday. The stock’s 50-day moving average price is $4.41 and its 200 day moving average price is $4.54. GoodRx Holdings, Inc. has a 12-month low of $3.68 and a 12-month high of $9.26. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.74. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of 58.51, a PEG ratio of 2.08 and a beta of 1.24.

GoodRx (NASDAQ:GDRX) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.04 by $0.05. The company had revenue of $202.97 million during the quarter, compared to analysts’ expectations of $202.25 million. GoodRx had a net margin of 3.57% and a return on equity of 7.85%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.08 EPS. As a group, sell-side analysts expect that GoodRx Holdings, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling

In related news, major shareholder Equity Vii L.P. Spectrum sold 10,677 shares of GoodRx stock in a transaction on Thursday, July 3rd. The shares were sold at an average price of $4.80, for a total transaction of $51,249.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 4.53% of the stock is owned by corporate insiders.

GoodRx Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.